QT
KURA icon

Quantamental Technologies’s Kura Oncology KURA Stock Holding History

Quantamental Technologies’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$2K – 1642
2019
Q1 		$2K Buy
+100
New +$1.54K ﹤0.01% 1381

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Quantamental Technologies's KURA Position: Q2 2019 in Review

Quantamental Technologies sold out of Kura Oncology (KURA) in Q2 2019, closing a stake of 100 shares — an estimated $2K sold.

Quantamental Technologies first reported a position in KURA in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 122 funds tracked by Wall St. Rank hold KURA as of Q2 2019.

  • Quantamental Technologies reported no remaining Kura Oncology position as of Q2 2019 after selling out during the quarter.
  • Quantamental Technologies sold 100 Kura Oncology shares in Q2 2019, an estimated $2K.
  • Quantamental Technologies first reported a position in Kura Oncology in Q1 2019 and held it in 1 quarter.
  • Quantamental Technologies's Kura Oncology position peaked at $2K in Q1 2019.
  • 122 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2019.

Based on Quantamental Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.